Thrombin-activable Fibrinolysis Inhibitor Zymogen Does Not Play a Significant Role in the Attenuation of Fibrinolysis

This publication has 32 references indexed in Scilit:

• Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors
  Journal of Thrombosis and Haemostasis, 2007
• The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal
  Journal of Thrombosis and Haemostasis, 2007
• A Kinetic Analysis of the Tissue Plasminogen Activator and DSPAα1 Cofactor Activities of Untreated and TAFIa-treated Soluble Fibrin Degradation Products of Varying Size
  Journal of Biological Chemistry, 2001
• Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties
  Published by Elsevier ,1998
• Characterisation and preliminary X‐ray diffraction analysis of human pancreatic procarboxypeptidase A2
  FEBS Letters, 1997
• Production and Characterization of Recombinant Human Plasminogen(S741C-Fluorescein)
  Journal of Biological Chemistry, 1997
• A Steady-state Template Model That Describes the Kinetics of Fibrin-stimulated [Glu1]- and [Lys78]Plasminogen Activation by Native tissue-type Plasminogen Activator and Variants That Lack Either the Finger or Kringle-2 Domain
  Journal of Biological Chemistry, 1997
• TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
  Published by Elsevier ,1996
• Plasma carboxypeptidases as regulators of the plasminogen system.
  Journal of Clinical Investigation, 1995
• Activation and Characterization of Procarboxypeptidase B from Human Plasma
  Biochemistry, 1995